Align Technology, Inc. (0HCK.L)
USD 183.98
(6.6%)
USD 183.98
(6.6%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -840.47 Million USD | 0.53% |
| 2022 | -815.14 Million USD | 16.31% |
| 2021 | -973.99 Million USD | -11.36% |
| 2020 | -874.66 Million USD | -78.06% |
| 2019 | -491.22 Million USD | 22.87% |
| 2018 | -636.89 Million USD | -41.69% |
| 2017 | -449.51 Million USD | -15.18% |
| 2016 | -390.27 Million USD | -132.7% |
| 2015 | -167.71 Million USD | 16.09% |
| 2014 | -199.87 Million USD | 17.73% |
| 2013 | -242.95 Million USD | 20.7% |
| 2012 | -306.38 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -739.38 Million USD | 8.81% |
| 2024 Q3 | -1.04 Billion USD | -52.42% |
| 2024 Q2 | -663.12 Million USD | 10.31% |
| 2023 Q2 | -818.53 Million USD | -16.0% |
| 2023 Q1 | -705.6 Million USD | 13.44% |
| 2023 FY | -810.81 Million USD | 0.53% |
| 2023 Q4 | -810.81 Million USD | 27.1% |
| 2023 Q3 | -1.11 Billion USD | -35.88% |
| 2022 Q3 | -923.65 Million USD | -22.41% |
| 2022 Q2 | -754.55 Million USD | 5.19% |
| 2022 Q1 | -795.89 Million USD | 18.29% |
| 2022 FY | -815.14 Million USD | 16.31% |
| 2022 Q4 | -815.14 Million USD | 11.75% |
| 2021 Q1 | -1.06 Billion USD | -19.13% |
| 2021 FY | -973.99 Million USD | -11.36% |
| 2021 Q4 | -973.99 Million USD | 14.66% |
| 2021 Q3 | -1.14 Billion USD | -15.33% |
| 2021 Q2 | -989.62 Million USD | 7.33% |
| 2020 Q4 | -896.39 Million USD | -62.98% |
| 2020 Q1 | -736.95 Million USD | -45.37% |
| 2020 Q3 | -550.01 Million USD | -55.49% |
| 2020 Q2 | -353.74 Million USD | 52.0% |
| 2020 FY | -874.66 Million USD | -78.06% |
| 2019 Q1 | -528.69 Million USD | 16.99% |
| 2019 FY | -491.22 Million USD | 22.87% |
| 2019 Q4 | -506.96 Million USD | -13.42% |
| 2019 Q3 | -446.99 Million USD | -22.68% |
| 2019 Q2 | -364.36 Million USD | 31.08% |
| 2018 Q2 | -547.99 Million USD | -10.04% |
| 2018 Q3 | -420.86 Million USD | 23.2% |
| 2018 Q4 | -636.89 Million USD | -51.33% |
| 2018 FY | -636.89 Million USD | -41.69% |
| 2018 Q1 | -498 Million USD | -10.79% |
| 2017 Q1 | -261.02 Million USD | 32.95% |
| 2017 FY | -449.51 Million USD | -15.18% |
| 2017 Q4 | -449.51 Million USD | -23.96% |
| 2017 Q3 | -362.61 Million USD | -1.24% |
| 2017 Q2 | -358.18 Million USD | -37.22% |
| 2016 Q4 | -389.27 Million USD | 7.3% |
| 2016 FY | -390.27 Million USD | -132.7% |
| 2016 Q3 | -419.94 Million USD | -150.41% |
| 2016 Q2 | -167.7 Million USD | -8.61% |
| 2016 Q1 | -154.41 Million USD | 7.93% |
| 2015 FY | -167.71 Million USD | 16.09% |
| 2015 Q4 | -167.71 Million USD | 3.63% |
| 2015 Q3 | -174.04 Million USD | -7.6% |
| 2015 Q2 | -161.75 Million USD | 14.86% |
| 2015 Q1 | -189.97 Million USD | 4.95% |
| 2014 Q1 | -182.76 Million USD | 24.77% |
| 2014 Q4 | -199.87 Million USD | -10.62% |
| 2014 FY | -199.87 Million USD | 17.73% |
| 2014 Q3 | -180.67 Million USD | -7.88% |
| 2014 Q2 | -167.47 Million USD | 8.37% |
| 2013 FY | -242.95 Million USD | 20.7% |
| 2013 Q3 | -175.83 Million USD | -6.89% |
| 2013 Q4 | -242.95 Million USD | -38.17% |
| 2013 Q1 | -328.74 Million USD | -7.3% |
| 2013 Q2 | -164.49 Million USD | 49.96% |
| 2012 Q4 | -306.38 Million USD | 0.0% |
| 2012 FY | -306.38 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | -1012.66% |
| Accuray Incorporated | 103.58 Million USD | 911.374% |
| Elevance Health Inc. | 18.59 Billion USD | 104.52% |
| AxoGen, Inc. | 32.26 Million USD | 2704.816% |
| Boston Scientific Corporation | 8.23 Billion USD | 110.21% |
| CVS Health Corporation | 71.18 Billion USD | 101.181% |
| Cardinal Health, Inc. | 476 Million USD | 276.569% |
| Centene Corporation | 506 Million USD | 266.101% |
| DaVita Inc. | 10.65 Billion USD | 107.89% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 102.054% |
| Hologic, Inc. | 374.4 Million USD | 324.485% |
| Humana Inc. | 5.51 Billion USD | 115.229% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 270.154% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 115.514% |
| Masimo Corporation | 804 Million USD | 204.536% |
| McKesson Corporation | 889 Million USD | 194.541% |
| Patterson Companies, Inc. | 648.47 Million USD | 229.607% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 117.947% |
| ResMed Inc. | 635.57 Million USD | 232.238% |
| Henry Schein, Inc. | 2.57 Billion USD | 132.703% |
| Teladoc Health, Inc. | 468.6 Million USD | 279.357% |
| Universal Health Services, Inc. | 5.24 Billion USD | 116.018% |
| Veeva Systems Inc. | -647.71 Million USD | -29.76% |
| Baxter International Inc. | 11.16 Billion USD | 107.527% |
| Becton, Dickinson and Company | 14.46 Billion USD | 105.811% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 68.407% |
| Danaher Corporation | 13.49 Billion USD | 106.229% |
| Stryker Corporation | 10.02 Billion USD | 108.385% |
| Medtronic plc | 23.67 Billion USD | 103.549% |